DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Moore K.
Primary results from IMagyn050/GOG 3015/ENGOT-OV39, a double-blind placebo-controlled randomised phase 3 trial of bevacizumab-containing therapy ± atezolizumab for newly diagnosed stage III/IV ovarian cancer. ESMO 2020.
J Clin Oncol 2021;
39: 1842-1855
DOI: 10.1200/JCO.21.00306.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.